Share Name Share Symbol Market Type Share ISIN Share Description
Widecells Group Plc LSE:WDC London Ordinary Share GB00BD060S65 ORD GBP0.0025
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.285 0.28 0.29 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -2.1 -1.0 - 4

Iconic Labs PLC Statement re Dispute with Greencastle

14/04/2021 7:00am

UK Regulatory (RNS & others)

Widecells (LSE:WDC)
Historical Stock Chart

From Jan 2021 to Jul 2021

Click Here for more Widecells Charts.


RNS Number : 3674V

Iconic Labs PLC

14 April 2021

14 April 2021

Iconic Labs Plc ("Iconic Labs" or the "Company")

Dispute with Greencastle Acquisition and others and investigation of former directors' conduct

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, announces that it has received (i) a statutory demand served by Greencastle Acquisition Limited for an amount (GBP58,668) alleged to be comprised of various sums assigned by John Quinlan, Liam Harrington and Samuel Regan Asante (the "Former Directors"), David Sefton, Matthew Vincent and Chris Pye less amounts owed by Greencastle entities to Iconic, including a GBP1,000,000 loan and management services fees; and (ii) a letter of demand from David Sefton claiming the amount of GBP256,676, allegedly comprising certain unpaid invoices. Such claims, which the Company believes are wholly without merit, will be vigorously defended by the Company in their entirety.

The Company has today sent a pre-action letter to Greencastle Acquisition Limited, Greencastle MM LLP, Greencastle Capital Limited, Linton Capital LLP and David Sefton, outlining a number of serious wrongdoings, including breaches of duty. Should the Company not receive a satisfactory response, the Company intends to issue proceedings in the Commercial Court in London.

The Company has also appointed forensic accounting and legal experts to assist with its investigation into further allegations of wrongdoing against the Former Directors and David Sefton.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.


For further information, please visit the Company's website or contact:

Iconic Labs

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

April 14, 2021 02:00 ET (06:00 GMT)

1 Year Widecells Chart

1 Year Widecells Chart

1 Month Widecells Chart

1 Month Widecells Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210729 11:57:03